After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, SLNO falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Soleno Therapeutics Inc is $1.97B. A total of 0.93 million shares were traded on the day, compared to an average of 529.70K shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, SLNO has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Yen Kristen sold 2,520 shares of SLNO for 45.41 per share on Jan 02 ’25. After the transaction, the insider now owns 78,945 company shares. In a previous transaction on Jan 03 ’25, Yen Kristen sold 2,340 shares at 46.18 per share. SLNO shares that the insider owns now total 76,605.
Among the insiders who sold shares, Mackaness James H disposed of 4,083 shares on Jan 02 ’25 at a per-share price of $45.41. This resulted in the CHIEF FINANCIAL OFFICER holding 115,089 shares of SLNO after the transaction. In another insider transaction, Mackaness James H sold 3,791 shares at $46.18 per share on Jan 03 ’25. Company shares held by the CHIEF FINANCIAL OFFICER now total 111,298.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for SLNO in the last 3 months, the mean price target is $74.25 with high estimates of $93.00 and low estimates of $67.00. In terms of 52-week highs and lows, SLNO has a high of $60.92 and a low of $36.61.
As of this writing, SLNO has an earnings estimate of $0 per share for the current quarter.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. SLNO’s latest balance sheet shows that the firm has $21.30M in Cash & Short Term Investments as of fiscal 2021. There were $457.00k in debt and $8.01M in liabilities at the time. Its Book Value Per Share was $5.36, while its Total Shareholder’s Equity was $17.79M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SLNO is Buy with a score of 5.00.
